US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEUROONE MEDICAL TECH

0.7803

+0.04536.16%

Post-market: 0.79990.0196+2.51%19:57 EST

Volume:266.47K

Turnover:201.54K

Market Cap:39.34M

PE:-8.67

High:0.7990

Open:0.7107

Low:0.7107

Close:0.7350

52wk High:1.25

52wk Low:0.3954

Shares:50.41M

Float Shares:43.60M

Volume Ratio:1.23

T/O Rate:0.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0900

EPS(LYR):-0.0898

ROE:-91.34%

ROA:-32.70%

PB:5.56

PE(LYR):-8.69

Loading ...

Overview Company News Filings

Neuroone Medical Technologies Corporation Files Initial Statement of Beneficial Ownership for Director Jason Richard Mills

NeuroOne Appoints Jason Mills to Board of Directors

Press Release: PNC Multifamily Capital Announces 100th Affordable Housing Fund; Driving Nationwide Impact

NeuroOne Medical Tech Q4 EPS $(0.04), Inline, Sales $2.741M Beat $2.470M Estimate

NeuroOne Medical Technologies reports FY license revenue of USD 3.0 million

NeuroOne Granted Nasdaq Extension to Regain Minimum Bid Price Compliance

BRIEF-Neuroone Medical Technologies - Expects Total Product Revenue In FY 2025 To Increase To $9.1 Million

NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand

Neuroone Medical Technologies - Expects Total Product Revenue in FY 2025 to Increase to $9.1 Mln

THOMSON REUTERS

Mark Christianson, Business Development Director, Reports Disposal of Common Shares in Neuroone Medical Technologies Corp

NeuroOne Medical Tech Initiated at Buy by Maxim Group

Maxim Initiates NeuroOne Medical Technologies at Buy With $3 Price Target

MT Newswires Live

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

NeuroOne Medical Technologies Gets FDA Clearance for OneRF Trigeminal Nerve Ablation System

MT Newswires Live

Neuroone® Receives FDA 510(K) Clearance for Onerf® Trigeminal Nerve Ablation System to Treat Facial Pain

THOMSON REUTERS

BRIEF-NeuroOne Medical Technologies Files Prospectus For $6.75 Million Share Sale

Neuroone Medical Technologies Corp - Files Prospectus for $6.75 Mln Share Sale - SEC Filing

THOMSON REUTERS

NeuroOne Medical Technologies Corporation Initiates ATM Program for Sale of Up to $6.75 Million in Shares Through JonesTrading

NeuroOne Q3 FY2025 Earnings Call Summary and Q&A Highlights: Revenue Growth, Margin Expansion, and Pipeline Progress

NeuroOne Medical Tech Q3 EPS $(0.03) Beats $(0.05) Estimate, Sales $1.70M Miss $1.82M Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NMTC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"NMTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMTC\",,,,,undefined,":{"symbol":"NMTC","market":"US","secType":"STK","nameCN":"NEUROONE MEDICAL TECH","latestPrice":0.7803,"timestamp":1770411600000,"preClose":0.735,"halted":0,"volume":266467,"hourTrading":{"tag":"盘后","latestPrice":0.7999,"preClose":0.7803,"latestTime":"19:57 EST","volume":915,"amount":711.099,"timestamp":1770425831289,"change":0.0196,"changeRate":0.025119,"amplitude":0.051262},"delay":0,"changeRate":0.0616326530612245,"floatShares":43602280,"shares":50413148,"eps":-0.09,"marketStatus":"Closed","change":0.0453,"latestTime":"02-06 16:00:00 EST","open":0.7107,"high":0.799,"low":0.7107,"amount":201541.782516,"amplitude":0.120136,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.09,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.735,"preHourTrading":{"tag":"盘前","latestPrice":0.7115,"preClose":0.735,"latestTime":"09:25 EST","volume":8134,"amount":5773.2960222,"timestamp":1770387900066,"change":-0.0235,"changeRate":-0.031973,"amplitude":0.09551},"postHourTrading":{"tag":"盘后","latestPrice":0.7999,"preClose":0.7803,"latestTime":"19:57 EST","volume":915,"amount":711.099,"timestamp":1770425831289,"change":0.0196,"changeRate":0.025119,"amplitude":0.051262},"volumeRatio":1.225811,"impliedVol":1.109,"impliedVolPercentile":0.4263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMTC\",,,,,undefined,":{"symbol":"NMTC","floatShares":43602280,"roa":"-32.70%","roe":"-91.34%","lyrEps":-0.089791,"volumeRatio":1.225811,"shares":50413148,"dividePrice":0,"high":0.799,"amplitude":0.120136,"preClose":0.735,"low":0.7107,"week52Low":0.3954,"pbRate":"5.56","psRate":"3.25","week52High":1.25,"institutionHeld":0,"latestPrice":0.7803,"eps":-0.09,"divideRate":0,"volume":266467,"delay":0,"ttmEps":-0.09,"open":0.7107,"prevYearClose":0.758,"prevWeekClose":0.885,"prevMonthClose":0.885,"prevQuarterClose":0.758},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-17","symbol":"NMTC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1765947600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-08-14","symbol":"NMTC","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.03},{"market":"US","date":"2025-05-13","symbol":"NMTC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-02-12","symbol":"NMTC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":0.06},{"market":"US","date":"2025-01-10","symbol":"NMTC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736485200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMTC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1757394000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMTC","date":"2026-02-05","current":-8.67,"percent":0.045635,"low":-13.710115,"twenty":-6.633189,"median":-3.004535,"eighty":-2.124669,"high":-1.439522,"avg":-4.379148,"sd":2.834974,"marketCap":40441427},"quantilePoints":[{"date":"2024-01-05","current":-3.152078,"twenty":-3.152078,"median":-3.152078,"eighty":-3.152078,"marketCap":37382041},{"date":"2024-01-12","current":-2.966641,"twenty":-3.158726,"median":-3.134059,"eighty":-3.111667,"marketCap":35182851},{"date":"2024-01-19","current":-2.88127,"twenty":-3.153408,"median":-3.039154,"eighty":-2.915418,"marketCap":34170395},{"date":"2024-01-26","current":-2.689185,"twenty":-3.123248,"median":-2.945298,"eighty":-2.872733,"marketCap":31892369},{"date":"2024-02-02","current":-3.038108,"twenty":-3.112542,"median":-2.923955,"eighty":-2.729733,"marketCap":36030419},{"date":"2024-02-09","current":-2.753969,"twenty":-3.070305,"median":-2.923955,"eighty":-2.729733,"marketCap":32660667},{"date":"2024-02-16","current":-2.021098,"twenty":-3.070305,"median":-2.902613,"eighty":-2.712471,"marketCap":27227472},{"date":"2024-02-23","current":-2.117341,"twenty":-3.046851,"median":-2.859927,"eighty":-2.587856,"marketCap":28524018},{"date":"2024-03-01","current":-2.329075,"twenty":-3.024994,"median":-2.753969,"eighty":-2.198185,"marketCap":31376420},{"date":"2024-03-08","current":-2.406069,"twenty":-2.999291,"median":-2.726527,"eighty":-2.225133,"marketCap":32413657},{"date":"2024-03-15","current":-2.059595,"twenty":-2.985273,"median":-2.710255,"eighty":-2.186636,"marketCap":27746090},{"date":"2024-03-22","current":-2.13659,"twenty":-2.973371,"median":-2.639564,"eighty":-2.13659,"marketCap":28783327},{"date":"2024-03-28","current":-2.319451,"twenty":-2.958104,"median":-2.489984,"eighty":-2.144289,"marketCap":31246765},{"date":"2024-04-05","current":-2.367572,"twenty":-2.936761,"median":-2.388746,"eighty":-2.163538,"marketCap":31895038},{"date":"2024-04-12","current":-2.329075,"twenty":-2.923955,"median":-2.386821,"eighty":-2.182786,"marketCap":31376420},{"date":"2024-04-19","current":-2.194335,"twenty":-2.906881,"median":-2.367572,"eighty":-2.182786,"marketCap":29561255},{"date":"2024-04-26","current":-2.13659,"twenty":-2.88127,"median":-2.348324,"eighty":-2.182786,"marketCap":28783327},{"date":"2024-05-03","current":-2.329075,"twenty":-2.864196,"median":-2.329075,"eighty":-2.175087,"marketCap":31376420},{"date":"2024-05-10","current":-2.232832,"twenty":-2.813481,"median":-2.324263,"eighty":-2.175087,"marketCap":30079874},{"date":"2024-05-17","current":-2.126501,"twenty":-2.767083,"median":-2.308772,"eighty":-2.155838,"marketCap":27227472},{"date":"2024-05-24","current":-2.207511,"twenty":-2.745226,"median":-2.271329,"eighty":-2.155838,"marketCap":28264709},{"date":"2024-05-31","current":-1.914053,"twenty":-2.732064,"median":-2.261705,"eighty":-2.146753,"marketCap":24507318},{"date":"2024-06-07","current":-1.846154,"twenty":-2.729733,"median":-2.252081,"eighty":-2.13659,"marketCap":23637945},{"date":"2024-06-14","current":-2.069476,"twenty":-2.721183,"median":-2.249194,"eighty":-2.126501,"marketCap":26497329},{"date":"2024-06-21","current":-1.804839,"twenty":-2.714657,"median":-2.232832,"eighty":-2.100768,"marketCap":23108945},{"date":"2024-06-28","current":-1.615657,"twenty":-2.712471,"median":-2.232832,"eighty":-2.078218,"marketCap":20686682},{"date":"2024-07-05","current":-1.848329,"twenty":-2.710255,"median":-2.232832,"eighty":-2.069476,"marketCap":23665787},{"date":"2024-07-12","current":-2.022507,"twenty":-2.689185,"median":-2.213584,"eighty":-2.039685,"marketCap":25895940},{"date":"2024-07-15","current":-2.065779,"twenty":-2.682608,"median":-2.213584,"eighty":-2.039817,"marketCap":26449997},{"date":"2024-08-02","current":-1.563469,"twenty":-2.676031,"median":-2.213584,"eighty":-2.030552,"marketCap":20018472},{"date":"2024-08-09","current":-1.611525,"twenty":-2.642911,"median":-2.207511,"eighty":-2.008766,"marketCap":20633782},{"date":"2024-08-16","current":-1.857244,"twenty":-2.587856,"median":-2.194335,"eighty":-1.98032,"marketCap":22477552},{"date":"2024-08-23","current":-2.011247,"twenty":-2.499067,"median":-2.187258,"eighty":-1.978947,"marketCap":24341385},{"date":"2024-08-30","current":-2.060127,"twenty":-2.444567,"median":-2.175087,"eighty":-1.978947,"marketCap":24932973},{"date":"2024-09-06","current":-1.960329,"twenty":-2.436867,"median":-2.155838,"eighty":-1.978799,"marketCap":23725147},{"date":"2024-09-13","current":-2.137268,"twenty":-2.402604,"median":-2.155838,"eighty":-1.978799,"marketCap":25866573},{"date":"2024-09-20","current":-2.380399,"twenty":-2.388361,"median":-2.155838,"eighty":-1.978873,"marketCap":28809107},{"date":"2024-09-27","current":-2.494964,"twenty":-2.436867,"median":-2.155838,"eighty":-1.979855,"marketCap":30195642},{"date":"2024-10-04","current":-2.36767,"twenty":-2.489872,"median":-2.175087,"eighty":-1.985012,"marketCap":28655048},{"date":"2024-10-11","current":-2.316752,"twenty":-2.515331,"median":-2.187258,"eighty":-1.994698,"marketCap":28038810},{"date":"2024-10-18","current":-2.36767,"twenty":-2.489872,"median":-2.194335,"eighty":-1.994929,"marketCap":28655048},{"date":"2024-10-25","current":-2.545627,"twenty":-2.489872,"median":-2.207511,"eighty":-1.996274,"marketCap":30808798},{"date":"2024-10-31","current":-2.507693,"twenty":-2.507693,"median":-2.213584,"eighty":-2.000544,"marketCap":30349701},{"date":"2024-11-08","current":-2.304023,"twenty":-2.494964,"median":-2.218396,"eighty":-2.001063,"marketCap":27884751},{"date":"2024-11-15","current":-1.988334,"twenty":-2.469505,"median":-2.223208,"eighty":-2.001063,"marketCap":24064078},{"date":"2024-11-22","current":-1.781608,"twenty":-2.469505,"median":-2.213584,"eighty":-1.994658,"marketCap":21562153},{"date":"2024-11-29","current":-1.586339,"twenty":-2.449555,"median":-2.210547,"eighty":-1.979094,"marketCap":19198882},{"date":"2024-12-06","current":-1.527529,"twenty":-2.444567,"median":-2.194335,"eighty":-1.954281,"marketCap":18487128},{"date":"2024-12-13","current":-1.94429,"twenty":-2.440892,"median":-2.194335,"eighty":-1.928958,"marketCap":23531032},{"date":"2024-12-20","current":-1.897865,"twenty":-2.422863,"median":-2.186912,"eighty":-1.922356,"marketCap":23378107},{"date":"2024-12-27","current":-2.155754,"twenty":-2.418434,"median":-2.175087,"eighty":-1.92028,"marketCap":26554815},{"date":"2025-01-03","current":-2.065117,"twenty":-2.413427,"median":-2.155838,"eighty":-1.925043,"marketCap":25438341},{"date":"2025-01-10","current":-2.704082,"twenty":-2.435695,"median":-2.175087,"eighty":-1.92625,"marketCap":33309176},{"date":"2025-01-17","current":-2.604181,"twenty":-2.469505,"median":-2.187085,"eighty":-1.927409,"marketCap":32078587},{"date":"2025-01-24","current":-2.804233,"twenty":-2.520423,"median":-2.194335,"eighty":-1.927409,"marketCap":34542849},{"date":"2025-01-31","current":-2.879346,"twenty":-2.5354,"median":-2.194335,"eighty":-1.93009,"marketCap":35468104},{"date":"2025-02-07","current":-2.485752,"twenty":-2.545627,"median":-2.210547,"eighty":-1.935379,"marketCap":30619768},{"date":"2025-02-14","current":-4.894803,"twenty":-2.57134,"median":-2.213584,"eighty":-1.94429,"marketCap":35183297},{"date":"2025-02-21","current":-4.80893,"twenty":-2.603981,"median":-2.223208,"eighty":-1.957121,"marketCap":34566047},{"date":"2025-02-28","current":-4.76771,"twenty":-2.660149,"median":-2.232832,"eighty":-1.960736,"marketCap":34269766},{"date":"2025-03-07","current":-4.379561,"twenty":-2.704082,"median":-2.232832,"eighty":-1.97462,"marketCap":31479792},{"date":"2025-03-14","current":-4.379561,"twenty":-2.72277,"median":-2.250637,"eighty":-1.978652,"marketCap":31479792},{"date":"2025-03-21","current":-4.293687,"twenty":-2.758113,"median":-2.252081,"eighty":-1.978799,"marketCap":30862542},{"date":"2025-03-28","current":-3.872906,"twenty":-2.809841,"median":-2.265835,"eighty":-1.979094,"marketCap":27838012},{"date":"2025-04-04","current":-3.692571,"twenty":-2.879346,"median":-2.271329,"eighty":-1.981914,"marketCap":26541786},{"date":"2025-04-11","current":-2.836056,"twenty":-2.879346,"median":-2.271329,"eighty":-1.981914,"marketCap":20385253},{"date":"2025-04-17","current":-3.722076,"twenty":-2.88127,"median":-2.290936,"eighty":-1.986041,"marketCap":26753867},{"date":"2025-04-25","current":-3.978521,"twenty":-2.932492,"median":-2.304023,"eighty":-1.992128,"marketCap":28597164},{"date":"2025-05-02","current":-4.074111,"twenty":-2.989597,"median":-2.313162,"eighty":-1.994779,"marketCap":29284255},{"date":"2025-05-09","current":-4.022031,"twenty":-3.032987,"median":-2.319451,"eighty":-1.995068,"marketCap":28909909},{"date":"2025-05-16","current":-4.707405,"twenty":-3.103727,"median":-2.329075,"eighty":-1.998409,"marketCap":31084905},{"date":"2025-05-23","current":-4.420369,"twenty":-3.162936,"median":-2.332028,"eighty":-2.000855,"marketCap":29189484},{"date":"2025-05-30","current":-4.580392,"twenty":-3.547773,"median":-2.342211,"eighty":-2.002081,"marketCap":30246181},{"date":"2025-06-06","current":-4.443572,"twenty":-3.692571,"median":-2.348324,"eighty":-2.006664,"marketCap":29342704},{"date":"2025-06-13","current":-4.330408,"twenty":-3.736512,"median":-2.367572,"eighty":-2.013283,"marketCap":28595437},{"date":"2025-06-20","current":-5.187436,"twenty":-3.852556,"median":-2.367572,"eighty":-2.01729,"marketCap":34254743},{"date":"2025-06-27","current":-5.507313,"twenty":-3.959974,"median":-2.36767,"eighty":-2.021293,"marketCap":36367019},{"date":"2025-07-03","current":-5.288529,"twenty":-4.048401,"median":-2.370216,"eighty":-2.022072,"marketCap":34922302},{"date":"2025-07-11","current":-5.654426,"twenty":-4.105755,"median":-2.386821,"eighty":-2.022507,"marketCap":37338467},{"date":"2025-07-18","current":-5.699692,"twenty":-4.164876,"median":-2.390937,"eighty":-2.024464,"marketCap":37637374},{"date":"2025-07-25","current":-6.8004,"twenty":-4.239877,"median":-2.393129,"eighty":-2.02754,"marketCap":44905796},{"date":"2025-08-01","current":-5.900369,"twenty":-4.298253,"median":-2.403927,"eighty":-2.036705,"marketCap":38962528},{"date":"2025-08-08","current":-5.733641,"twenty":-4.336624,"median":-2.418585,"eighty":-2.039501,"marketCap":37861554},{"date":"2025-08-15","current":-6.262613,"twenty":-4.383972,"median":-2.44227,"eighty":-2.039685,"marketCap":41354567},{"date":"2025-08-22","current":-7.207503,"twenty":-4.422498,"median":-2.453704,"eighty":-2.040347,"marketCap":38464629},{"date":"2025-08-29","current":-6.922688,"twenty":-4.469882,"median":-2.477628,"eighty":-2.041797,"marketCap":36944644},{"date":"2025-09-05","current":-6.847737,"twenty":-4.555446,"median":-2.501329,"eighty":-2.046432,"marketCap":36544648},{"date":"2025-09-12","current":-8.378617,"twenty":-4.597456,"median":-2.520423,"eighty":-2.051997,"marketCap":44714569},{"date":"2025-09-19","current":-8.431083,"twenty":-4.637182,"median":-2.533385,"eighty":-2.058296,"marketCap":44994567},{"date":"2025-09-26","current":-8.422651,"twenty":-4.748744,"median":-2.545627,"eighty":-2.059595,"marketCap":44949567},{"date":"2025-10-03","current":-8.43202,"twenty":-4.80893,"median":-2.57134,"eighty":-2.060021,"marketCap":44999567},{"date":"2025-10-10","current":-9.649979,"twenty":-4.894803,"median":-2.603931,"eighty":-2.064119,"marketCap":51499504},{"date":"2025-10-17","current":-8.087244,"twenty":-4.979507,"median":-2.613504,"eighty":-2.065647,"marketCap":43159584},{"date":"2025-10-24","current":-7.449221,"twenty":-5.11984,"median":-2.656301,"eighty":-2.067453,"marketCap":39754617},{"date":"2025-10-31","current":-7.420178,"twenty":-5.245376,"median":-2.684115,"eighty":-2.068397,"marketCap":39599619},{"date":"2025-11-07","current":-6.731563,"twenty":-5.329268,"median":-2.704082,"eighty":-2.069287,"marketCap":35924654},{"date":"2025-11-14","current":-6.351185,"twenty":-5.483171,"median":-2.717104,"eighty":-2.069476,"marketCap":33894673},{"date":"2025-11-21","current":-5.630716,"twenty":-5.576117,"median":-2.731871,"eighty":-2.073653,"marketCap":30049710},{"date":"2025-11-28","current":-6.509519,"twenty":-5.650352,"median":-2.753969,"eighty":-2.076342,"marketCap":34739665},{"date":"2025-12-05","current":-6.286539,"twenty":-5.800332,"median":-2.79003,"eighty":-2.077812,"marketCap":33549677},{"date":"2025-12-12","current":-5.480813,"twenty":-5.901562,"median":-2.832275,"eighty":-2.078531,"marketCap":29249718},{"date":"2025-12-19","current":-9.930913,"twenty":-6.016853,"median":-2.83732,"eighty":-2.087167,"marketCap":35804655},{"date":"2025-12-26","current":-10.708012,"twenty":-6.150128,"median":-2.866827,"eighty":-2.095872,"marketCap":38606388},{"date":"2026-01-02","current":-10.598946,"twenty":-6.204301,"median":-2.879346,"eighty":-2.101735,"marketCap":38213166},{"date":"2026-01-09","current":-12.478232,"twenty":-6.281754,"median":-2.88127,"eighty":-2.107616,"marketCap":44988693},{"date":"2026-01-16","current":-12.570518,"twenty":-6.375169,"median":-2.923955,"eighty":-2.113934,"marketCap":45321420},{"date":"2026-01-23","current":-12.110485,"twenty":-6.427713,"median":-2.95597,"eighty":-2.117341,"marketCap":43662827},{"date":"2026-01-30","current":-12.165018,"twenty":-6.504835,"median":-2.987984,"eighty":-2.117341,"marketCap":43859438},{"date":"2026-02-05","current":-11.216985,"twenty":-6.633189,"median":-3.004535,"eighty":-2.124669,"marketCap":40441427}],"updateTime":1770438433910},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMTC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2600648180","title":"Neuroone Medical Technologies Corporation Files Initial Statement of Beneficial Ownership for Director Jason Richard Mills","url":"https://stock-news.laohu8.com/highlight/detail?id=2600648180","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600648180?lang=en_us&edition=fundamental","pubTime":"2026-01-03 00:56","pubTimestamp":1767373006,"startTime":"0","endTime":"0","summary":"Neuroone Medical Technologies Corporation has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Jason Richard Mills as the beneficial owner in his capacity as Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL3XknmH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Neuroone Medical Technologies Corporation Files Initial Statement of Beneficial Ownership for Director Jason Richard Mills","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2593809114","title":"NeuroOne Appoints Jason Mills to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2593809114","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593809114?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:14","pubTimestamp":1766409273,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies Corporation has appointed Jason Mills to its Board of Directors, effective December 18, 2025. Mills is currently Executive Vice President of Strategy at Penumbra, Inc. and brings extensive experience in med-tech strategy, business development, and investment analysis. He will also serve on NeuroOne’s Compensation and Nominating & Corporate Governance Committees.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the informatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL5gmhtz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4548","PEN","BK4082"],"gpt_icon":0},{"id":"2592491326","title":"Press Release: PNC Multifamily Capital Announces 100th Affordable Housing Fund; Driving Nationwide Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2592491326","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592491326?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:05","pubTimestamp":1765980300,"startTime":"0","endTime":"0","summary":"New $175 million fund to support 17 developments, creating homes for families, seniors and vulnerable populations.PITTSBURGH, Dec. 17, 2025 /PRNewswire/ -- PNC Bank, N.A., a tax credit syndication leader, today announced the closing of Low-Income Housing Tax Credit  Fund 100, which is investing more than $175 million in the development and rehabilitation of affordable rental housing across the U.S. The fund includes investments from PNC and six other financial services and insurance companies.This milestone marks the 100th fund sponsored by PNC and underscores its long-standing commitment to creating and preserving affordable housing across the United States. The investment will support the construction or rehabilitation of nearly 1,500 affordable homes in 17 properties across 10 states and the District of Columbia, including California, Colorado, Georgia, Illinois, Maryland, Oregon, Tennessee, Texas, Virginia, Washington and Washington, D.C., helping families, seniors and vulnerable p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","LU0048573561.USD","LU0170899867.USD","LU0971096721.USD","IE000M9KFDE8.USD","BK4211","BK4504","LU0052756011.USD","LU0070302665.USD","PNC","LU1267930227.SGD","LU0251131958.USD","LU1363072403.SGD","LU0320765489.SGD","BK4585","NMTC","BK4588","BK4566","LU0742534661.SGD","LU0310800965.SGD","BK4207","LU0208291251.USD","BK4082","LU0251142724.SGD"],"gpt_icon":0},{"id":"2592994639","title":"NeuroOne Medical Tech Q4 EPS $(0.04), Inline, Sales $2.741M Beat $2.470M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994639","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994639?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:40","pubTimestamp":1765971641,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 63.64 percent increase over losses of $(0.11) per share from the same period last","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49443570/neuroone-medical-tech-q4-eps-0-04-inline-sales-2-741m-beat-2-470m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2592918499","title":"NeuroOne Medical Technologies reports FY license revenue of USD 3.0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918499","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918499?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:01","pubTimestamp":1765969281,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies Corporation reported its financial results for the full year ending September 30, 2025. License revenue was USD 3.0 million for the period, primarily related to the distribution license granted to Zimmer for the OneRF Ablation System in October 2024. Cost of product revenue included manufacturing and materials costs, as well as royalty fees of approximately USD 150 thousand for the year. Selling, general and administrative expenses totaled USD 7.4 million for the same period. The company stated that it expects to satisfy its short-term and long-term obligations through cash on hand and revenue from commercial sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL7TKmkT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2581773306","title":"NeuroOne Granted Nasdaq Extension to Regain Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581773306","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581773306?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:55","pubTimestamp":1762350937,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies Corporation has announced that it received a notice from Nasdaq granting a 180-day extension, until May 4, 2026, to regain compliance with the stock exchange's minimum bid price requirement of $1.00 per share. The company's shares had previously fallen below this threshold for 30 consecutive business days, triggering a warning in May 2025. While the extension allows NeuroOne's stock to remain listed on the Nasdaq Capital Market for now, failure to meet the requirement by the new deadline could result in a delisting, subject to appeal. The company has stated its intention to take action to regain compliance within the extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technolo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLb3jWFJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2573598119","title":"BRIEF-Neuroone Medical Technologies - Expects Total Product Revenue In FY 2025 To Increase To $9.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2573598119","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573598119?lang=en_us&edition=fundamental","pubTime":"2025-10-07 06:45","pubTimestamp":1759790724,"startTime":"0","endTime":"0","summary":"BRIEF-Neuroone Medical Technologies - Expects Total Product Revenue In FY 2025 To Increase To $9.1 MillionOct 6  - Neuroone Medical Technologies Corp NMTC.O:NEUROONE MEDICAL TECHNOLOGIES - EXPECTS TOTAL PRODUCT REVENUE IN FY 2025 TO INCREASE TO $9.1 MILLIONSource text: [ID:n0001213900-25-096548]Further company coverage: NMTC.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1TN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2573744983","title":"NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand","url":"https://stock-news.laohu8.com/highlight/detail?id=2573744983","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573744983?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:40","pubTimestamp":1759783207,"startTime":"0","endTime":"0","summary":" Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results:  ●Achieved annual total product revenue of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48056673/neuroone-medical-technologies-reports-preliminary-fy25-results-of-9-1m-product-revenue-and-6-6m-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2573298333","title":"Neuroone Medical Technologies - Expects Total Product Revenue in FY 2025 to Increase to $9.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2573298333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573298333?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:22","pubTimestamp":1759782153,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1TN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2566648742","title":"Mark Christianson, Business Development Director, Reports Disposal of Common Shares in Neuroone Medical Technologies Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2566648742","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566648742?lang=en_us&edition=fundamental","pubTime":"2025-09-10 04:16","pubTimestamp":1757448989,"startTime":"0","endTime":"0","summary":"Mark Christianson, the Business Development Director, reported a disposal of common shares of Neuroone Medical Technologies Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL1YdSKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2566615627","title":"NeuroOne Medical Tech Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2566615627","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566615627?lang=en_us&edition=fundamental","pubTime":"2025-09-09 22:34","pubTimestamp":1757428440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMTC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 09, 2025 10:34 ET (14:34 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2566183694","title":"Maxim Initiates NeuroOne Medical Technologies at Buy With $3 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2566183694","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566183694?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:56","pubTimestamp":1757419001,"startTime":"0","endTime":"0","summary":"Maxim Initiates NeuroOne Medical Technologies at Buy With $3 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMTC"],"gpt_icon":0},{"id":"2566632937","title":"NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2566632937","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566632937?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361900,"startTime":"0","endTime":"0","summary":"EDEN PRAIRIE, Minn., Sept.  08, 2025  (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (\"NeuroOne\" or the \"Company\"), a medical technology company focused on improving surg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/08/3146446/0/en/NeuroOne-to-Participate-in-Sidoti-Small-Cap-Conference-on-September-17th-and-18th-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2560900108","title":"NeuroOne Medical Technologies Gets FDA Clearance for OneRF Trigeminal Nerve Ablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2560900108","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560900108?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:56","pubTimestamp":1755521770,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies (NMTC) said Monday that the US Food and Drug Administration has cleared its OneRF Trigeminal Nerve Ablation System for procedures treating chronic pain and for functional","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2560074859","title":"Neuroone® Receives FDA 510(K) Clearance for Onerf® Trigeminal Nerve Ablation System to Treat Facial Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2560074859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560074859?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:30","pubTimestamp":1755520200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA9WJSCJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2559941520","title":"BRIEF-NeuroOne Medical Technologies Files Prospectus For $6.75 Million Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2559941520","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559941520?lang=en_us&edition=fundamental","pubTime":"2025-08-16 06:53","pubTimestamp":1755298381,"startTime":"0","endTime":"0","summary":"BRIEF-NeuroOne Medical Technologies Files Prospectus For $6.75 Million Share SaleAug 15  - Neuroone Medical Technologies Corp NMTC.O:NEUROONE MEDICAL TECHNOLOGIES CORP - FILES PROSPECTUS FOR $6.75 MILLION SHARE SALE - SEC FILINGSource text: [ID:n0001213900-25-077511]Further company coverage: NMTC.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U70XJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2559462529","title":"Neuroone Medical Technologies Corp - Files Prospectus for $6.75 Mln Share Sale - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2559462529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559462529?lang=en_us&edition=fundamental","pubTime":"2025-08-16 04:45","pubTimestamp":1755290704,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U70XJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2559462359","title":"NeuroOne Medical Technologies Corporation Initiates ATM Program for Sale of Up to $6.75 Million in Shares Through JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2559462359","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559462359?lang=en_us&edition=fundamental","pubTime":"2025-08-16 04:41","pubTimestamp":1755290464,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies Corporation Initiates ATM Program for Sale of Up to $6.75 Million in Shares Through JonesTrading. NeuroOne Medical Technologies Corporation has entered into a Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC. Under this agreement, NeuroOne may sell up to $6.75 million worth of its common stock through JonesTrading in an \"at the market offering.\" Further details on the number of shares and specific pricing were not disclosed in the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL2z8MrJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"1157619024","title":"NeuroOne Q3 FY2025 Earnings Call Summary and Q&A Highlights: Revenue Growth, Margin Expansion, and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1157619024","media":"Earnings Call","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157619024?lang=en_us&edition=fundamental","pubTime":"2025-08-14 23:12","pubTimestamp":1755184323,"startTime":"0","endTime":"0","summary":"[Management View]NeuroOne reported strong financial performance in Q3 FY2025, with product revenue increasing 105% YoY to $1.7 million and product gross margins improving to 53.9% from 34.1% YoY....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC"],"gpt_icon":0},{"id":"2559295123","title":"NeuroOne Medical Tech Q3 EPS $(0.03) Beats $(0.05) Estimate, Sales $1.70M Miss $1.82M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559295123","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559295123?lang=en_us&edition=fundamental","pubTime":"2025-08-14 19:31","pubTimestamp":1755171060,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 70 percent increase over losses of $(0.10) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47118161/neuroone-medical-tech-q3-eps-0-03-beats-0-05-estimate-sales-1-70m-miss-1-82m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}